Renalytix plc - ADS (RNLXY)

CUSIP: 75973T101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / ADS
Total 13F shares
3,567,423
Share change
+276,594
Total reported value
$10,415,025
Put/Call ratio
110%
Price per share
$2.92
Number of holders
20
Value change
+$818,688
Number of buys
16
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q2 2023

As of 30 Jun 2023, Renalytix plc - ADS (RNLXY) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,567,423 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, PINNACLE ASSOCIATES LTD, Pentwater Capital Management LP, Tejara Capital Ltd, Corient Private Wealth LLC, LAZARD ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and North Star Investment Management Corp.. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.